Clinical TrialsSearch results
Number of results: 865
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A multicenter, observational study for reactivation of hepatitis B virus by means of serial HBV-DNA monitoring during and just after systemic chemotherapy containing rituximab plus steroid for malignant lymphoma (C-SHOT 0802)
- Untreated CD20-positive, B-cell non-Hodgkin's lymphoma in the patients with seronegativity for HBsAg and seropositivity for HBc-Ab and/or HBs-Ab, which is planned to be treated with 6-8 courses of systemic chemotherapy containing rituximab plus steroid such as R-CHOP, R-CVP, R-THP-COP and R-C-MOPP
- Nagoya City University Hospital
- 2008-08-11
Other
- Rituximab + standard CHOP (R S-CHOP) vs Rituximab + bi-weekly CHOP (R Bi-CHOP) RCT(phase II/III) low-grade B-cell lymphoma at advanced stage (LowBNHL-RS/BiCHOP-P2/3) (JCOG0203)
- Untreated CD20-positive low-grade B-cell lymphoma at advanced stage
- Japan Clinical Oncology Group(JCOG)
- 2005-07-30
Other
- Unruptured Cerebral Aneurysm Study in Japan
- Unruptured intracranial aneurysms
- Society of Japan Neurosurgical Society
- 2006-05-17
Recruiting
- Triplet rechallenge of BEACON regimen for RAS wild-type and BRAF V600E mutant metastatic colorectal cancer
- Unresectable, advanced or recurrent colorectal cancer with RAS wild-type and BRAF V600E mutation
- Kotani Daisuke
- 2022-01-01
Recruiting
- Addition of binimetinib after refractory to encorafenib and cetuximab in patients with BRAF V600E-mutant metasta
tic colorectal cancer
- Unresectable, advanced or recurrent colorectal cancer with BRAF V600E mutation
- Bando Hideaki
- 2022-01-01
Other
- A phase I study of niraparib and pimitespib in patients with solid tumor
- unresectable recurrent solid tumor
- Naito Yoichi
- 2022-07-02
Other
- Randomized phase III study of CPT-11 versus Weekly Paclitaxel for unresectable or recurrent gastric cancer refractory to combination chemotherapy with fluoropyrimidine plus platinum.
- unresectable or recurrent gastric cancer refractory to combination chemotherapy with fluoropyrimidine plus platinum
- West Japan Oncology Group
- 2008-07-15
Other
- Phase I/II Study of Combination Therapy of Oral Fluorinated Pyrimidine Compound S-1 with Low-dose Cisplatin in Patients with Unresectable and/or Recurrent Advanced Gastric Cancer
Step 2: low dose cisplatin given twice a week + S-1
- unresectable or recurrent gastric cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2005-11-14
Recruiting
- Feasibility study evaluating Paclitaxel, Carboplatin and Cetuximab (PCE) as induction chemotherapy followed by chemoradiation in patients with Unresectable Locally advanced Squamous Cell Carcinoma of the Head and Neck
- Unresectable Locally advanced Squamous Cell Carcinoma of the Head and Neck
- Tahara Makoto
- 2019-03-18
Other
- Phase II trial of chemoradiotherapy concurrent with S-1 plus cisplatin in patients with unresectable locally advanced squamous cell carcinoma of the head and neck (JCOG0706)
- unresectable locally advanced squamous cell carcinoma of the head and neck
- Japan Clinical Oncology Group (JCOG)
- 2008-07-28